Pharmaessentia Is A Global Biopharmaceutical Company Founded In 2003Focused On Developing Safe And Effective Therapeutic Products For Human Diseasesparticularly Hematologic Diseases And Conditions Like Myeloproliferative Neoplasms And Hepatitisthe Company Is Publicly Traded On The Taipei Exchange Under The Ticker Symbol 6446 Two The Companyae S Key Product Is Ropeginterferon Alfa 2B Njftp1101 Which Utilizes Pegylation Technology To Enhance The Duration Of Interferon Activity For Treating Myeloproliferative Neoplasmspharmaessentia Operates A State Of The Art Cgmp Biologics Facility In Taichungtaiwancertified By The Taiwan Food And Drug Administration And Compliant With U Sfda And Ema Standardswith A Strong Presence In The Americasthe Company Is Led By Meredith Manningwho Drives Its Strategic Growth In The Regionpharmaessentia Is Committed To Expanding Its Research And Development Efforts Globallyaiming To Improve Treatment Options For Patients Worldwide
No conferences found for this company.
| Company Name | Pharmaessentia Usa Corporation |
| Country |
United States
|
| Address | 35 Corporate Dr 325 Burlington Ma 01803 Usa |
| Telephone | Login to View |
| Login to View |
